| Jenna Kay Crawford, | |
|
19401 S Vermont Ave Ste A200, Torrance, CA 90502-4418 | |
| (310) 323-6887 | |
| (310) 323-1570 |
| Full Name | Jenna Kay Crawford |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 19401 S Vermont Ave Ste A200, Torrance, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063758993 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| 101Y00000X | Counselor | (* (Not Available)) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Jenna Kay Crawford, 11331 Se Rimrock Dr, Happy Valley, OR 97086-7153 Ph: (503) 830-6947 | Jenna Kay Crawford, 19401 S Vermont Ave Ste A200, Torrance, CA 90502-4418 Ph: (310) 323-6887 |
News Archive
Children whose mothers are genetically predisposed to have impaired production of serotonin appear more likely to develop attention-deficit hyperactivity disorder (ADHD) later in life, according to a report in the October issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
Haldimand War Memorial Hospital and Edgewater Gardens select Shared Services West as its Preferred Supplier for Supply Chain Services.
Althea Technologies, Inc., a leading provider of development and manufacturing services for biopharmaceuticals and parenteral drug products, announced today that it has completed the installation of a new INOVA H3-5 high-speed syringe filling line.
The peer reviewed guidelines will be available in the September 2010 issue, (Volume 53, No.3) of the Journal of Hepatology and online in advance of publication at http://www.ncbi.nlm.nih.gov/pubmed/20633946 . They also provide recommendations for the management of spontaneous bacterial peritonitis and hepatorenal syndrome, which often affect patients with cirrhosis.
Plexxikon today announced that updated Phase 1 clinical data of Zelboraf (vemurafenib) were presented at the Society for Melanoma Research (SMR) 2012 Congress, held November 8-11 in Los Angeles, CA.
› Verified 6 days ago
Mr. Joel Brandon Nelson, CADC I Counselor Medicare: Not Enrolled in Medicare Practice Location: 1000 W Carson, Torrance, CA 90502 Phone: 424-306-5813 | |
Liliana Silva, Counselor Medicare: Not Enrolled in Medicare Practice Location: 4025 W 226th St, Torrance, CA 90505 Phone: 310-373-4556 | |
Adriana Ramirez, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1617 Cravens Ave, Torrance, CA 90501 Phone: 310-328-0855 | |
Wendy Lorraine Rafferty, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1334 Post Ave, Torrance, CA 90501 Phone: 310-328-1460 | |
Vanessa Beltran, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1124 West Carson Street, N-33, Torrance, CA 90502 Phone: 323-457-1898 | |
Robbie Racheal Harris-depriest, CTRS Counselor Medicare: Not Enrolled in Medicare Practice Location: 1000 W Carson St, Torrance, CA 90502 Phone: 310-222-1648 Fax: 310-222-5651 | |
Lynda Sanchez, CATC 169294 Counselor Medicare: Not Enrolled in Medicare Practice Location: 1124 W Carson St # 33, Torrance, CA 90502 Phone: 310-222-5410 Fax: 310-787-7742 |